Predictive Factors of Lymph Node Status in Small Peripheral Non-small Cell Lung Cancers: Tumor Histology is More Reliable

Zhang, Yang; Sun, Yihua; Shen, Lei; Li, Yuan; Xiang, Jiaqing; Zhang, Yawei; Hu, Hong; Chen, Haiquan
June 2013
Annals of Surgical Oncology: An Oncology Journal for Surgeons;Jun2013, Vol. 20 Issue 6, p1949
Academic Journal
No abstract available.


Related Articles

  • HER-2/NEU ONCOGENE AND ESTROGENE RECEPTOR EXPRESSION IN NON SMALL CELL LUNG CANCER PATIENTS. Alerić, Ivan; Razumović, Jasminka Jakic; Koprivica, Branka // Medicinski Pregled / Medical Review;May/Jun2012, Vol. 65 Issue 5/6, p210 

    Non-small cell lung cancers are among the leading causes of cancer morbidity and mortality worldwide. The prognosis is usually based on traditional pathohistological parameters and clinical stage, but additional prognostic survival factors have also been sought. The aim of this retrospective...

  • Clinical significance of serum and tumor tissue endostatin evaluation in operable non-small cell lung cancer. MING-MING HU; YING HU; HAI-QING ZHANG; WEN-YUN JIA; ZHE QIAN; YUAN YANG; BAO-LAN LI // Biomedical Reports;2014, Vol. 2 Issue 6, p898 

    Endostatin, as the most potential antiangiogenic factor, is a naturally occurring fragment of collagen XVIII in bloodstream capable of inhibiting tumor growth and metastasis. This study was conducted to explore the clinical value of endostatin in serum and tumor tissue in patients with operable...

  • Sentinel lymph node biopsy progress in surgical treatment of cancer. Schulze, T.; Bembenek, A.; Schlag, P. M. // Langenbeck's Archives of Surgery;Dec2004, Vol. 389 Issue 6, p532 

    Background: Forty-three years after the first description of the sentinel lymph node technique in malignant tumours of the parotid by Gould, sentinel lymph node biopsy (SNLB) has become a precious tool in the treatment of solid tumours. Methods: In the following review we give a synopsis of the...

  • The prognostic factors of resected non-small cell lung cancer with chest wall invasion.  // World Journal of Surgical Oncology;2012, Vol. 10 Issue 1, p9 

    The article presents a study investigating the prognostic factors that impact long term survival in patients with a surgically resected non-small cell lung cancer (NSCLC) invading chest wall. It is mentioned that completeness of resection, tumor size, and adjuvant chemotherapy were among several...

  • Predicting survival of patients with resectable non-small cell lung cancer: Beyond TNM. Osarogiagbon, Raymond U. // Journal of Thoracic Disease;Apr2012, Vol. 4 Issue 2, p214 

    The article discusses few reasons for poor results in predicting survival of patients with resectable non-small cell lung cancer (NSCLC). Some of these include biologic heterogeneity; the limitations of current staging/prognostic tools; and poor application of our current best prognostic tool,...

  • Prognosis associated with surgery for non-small cell lung cancer and synchronous brain metastasis. Kanou, Takashi; Okami, Jiro; Tokunaga, Toshiteru; Fujiwara, Ayako; Ishida, Daisuke; Kuno, Hidenori; Higashiyama, Masahiko // Surgery Today;Jul2014, Vol. 44 Issue 7, p1321 

    Purpose: Several reports have described extended survival after aggressive surgical treatment for non-small cell lung cancer (NSCLC) and synchronous brain metastasis. This retrospective analysis assesses the prognostic factors in this population. Methods: We reviewed retrospectively the medical...

  • CXCL12-3′ A Polymorphism and lung cancer metastases protection: new perspectives in immunotherapy? Coelho, Ana; Calçada, Carmen; Catarino, Raquel; Pinto, Daniela; Fonseca, Graça; Medeiros, Rui // Cancer Immunology, Immunotherapy;Jun2006, Vol. 55 Issue 6, p639 

    The article evaluates the genetic influence of CXCL12-3' A polymorphism in the susceptibility to lung cancer development. There are two major groups of lung carcinomas: small cell lung cancer and non-small cell lung cancer. Non-small cell lung cancer metastases to regional lymph nodes, liver,...

  • Research Progress of Lobe-specific Lymphadenectomy on early stage Lung Cancer Operation. Jian CHEN; Yang SHEN-TU // Chinese Journal of Lung Cancer;Jan2011, Vol. 14 Issue 1, p63 

    Systematic nodes dissection be the standard procedure for lung cancer during operation. While Surgery for early lung cancer lymph node removal method has been controversial, particularly for clinical early stage non-small cell lung cancer that has presenced several methods of lymph node...

  • Endoscopic (oesophageal) ultrasound guided fine needle aspiration (EUS-FNA). Richardson, C. M.; Peake, M. D. // Thorax;Jul2004, Vol. 59 Issue 7, p546 

    The management of lung cancer depends to a great extent on its histological type and the stage of disease. Although most patients with non-small cell lung cancer (NSCLC) have advanced disease at presentation, approximately 30% have tumour confined to the lung and locoregional lymph nodes. In...

  • Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry. Kluk, Michael J.; Ashworth, Todd; Wang, Hongfang; Knoechel, Birgit; Mason, Emily F.; Morgan, Elizabeth A.; Dorfman, David; Pinkus, Geraldine; Weigert, Oliver; Hornick, Jason L.; Chirieac, Lucian R.; Hirsch, Michelle; Oh, David J.; South, Andrew P.; Leigh, Irene M.; Pourreyron, Celine; Cassidy, Andrew J.; DeAngelo, Daniel J.; Weinstock, David M.; Krop, Ian E. // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Fixed, paraffin-embedded (FPE) tissues are a potentially rich resource for studying the role of NOTCH1 in cancer and other pathologies, but tests that reliably detect activated NOTCH1 (NICD1) in FPE samples have been lacking. Here, we bridge this gap by developing an immunohistochemical (IHC)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics